Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000
Technique(s):
immunohistochemistry: suitable
Detection method:
colorimetric
Quality Level
manufacturer/tradename
OxyIHC
technique(s)
immunohistochemistry: suitable
detection method
colorimetric
General description
Reactive oxygen species (ROS) have been implicated in pathological processes including cancer,
apoptosis, aging, neurodegenerative diseases, chronic inflammatory diseases, pulmonary diseases, and
cardiovascular diseases (for reviews, see ref. 1-4). Living organisms are continually exposed to potentially
harmful oxygen free radicals that are generated thru normal cellular functions as well as from environmental
factors (1, 5-7). Yet, these reactive molecules are mitigated by the presence of antioxidants and therefore
organisms exist with a delicate balance between oxidants and antioxidants (7-9). During times of oxidative
stress there is an imbalance in favor of the oxidants. The end result of which is that free radicals are able to
attack and modify sub-cellular components including nucleic acids, lipids and proteins (7, 10-12).
Proteins are one of the major targets of reactive species. Oxidation of proteins modifies the side chains of
methionine, histidine, and tyrosine and forms cysteine disulfide bonds (16-19). Metal catalyzed oxidation of
proteins introduces carbonyl groups (aldehydes and ketones) at lysine, arginine, proline or threonine
residues in a site-specific manner (16, 20-22). The oxidative modification of proteins can modulate
biochemical characteristics of proteins such as enzymatic activity (21-23), DNA binding activities of
transcription factors (24-26), and the susceptibility to proteolytic degradation (12, 25-28). While a
relationship between protein oxidation and aging has been suggested (29-31), little is known about the
importance of oxidative modification of individual proteins in the pathophysiology of free radical mediated
processes. Not surprisingly, carbonyl modification of proteins has become a key biomarker for the
identification of oxidative stress.
apoptosis, aging, neurodegenerative diseases, chronic inflammatory diseases, pulmonary diseases, and
cardiovascular diseases (for reviews, see ref. 1-4). Living organisms are continually exposed to potentially
harmful oxygen free radicals that are generated thru normal cellular functions as well as from environmental
factors (1, 5-7). Yet, these reactive molecules are mitigated by the presence of antioxidants and therefore
organisms exist with a delicate balance between oxidants and antioxidants (7-9). During times of oxidative
stress there is an imbalance in favor of the oxidants. The end result of which is that free radicals are able to
attack and modify sub-cellular components including nucleic acids, lipids and proteins (7, 10-12).
Proteins are one of the major targets of reactive species. Oxidation of proteins modifies the side chains of
methionine, histidine, and tyrosine and forms cysteine disulfide bonds (16-19). Metal catalyzed oxidation of
proteins introduces carbonyl groups (aldehydes and ketones) at lysine, arginine, proline or threonine
residues in a site-specific manner (16, 20-22). The oxidative modification of proteins can modulate
biochemical characteristics of proteins such as enzymatic activity (21-23), DNA binding activities of
transcription factors (24-26), and the susceptibility to proteolytic degradation (12, 25-28). While a
relationship between protein oxidation and aging has been suggested (29-31), little is known about the
importance of oxidative modification of individual proteins in the pathophysiology of free radical mediated
processes. Not surprisingly, carbonyl modification of proteins has become a key biomarker for the
identification of oxidative stress.
The OxyIHC Oxidative Stress Detection Kit (S7450) contains the chemical and immunological reagents
necessary to detect protein oxidation in various tissues from a variety of organs and animal species. The
OxyIHC test method involves chemical derivatization of protein carbonyl groups with 2,4-
dinitrophenylhydrazine (DNPH). This chemical reaction results in proteins being covalently coupled to DNP
at their carbonyl sites. The DNP-derivatized proteins are then detected using an antibody that specifically
binds to the DNP moiety. Subsequent incubation with biotin conjugated secondary antibody, streptavidin
conjugated HRP, and development using a 3,3’ diaminobenzidine (DAB) staining allows
immunohistochemical detection of protein oxidation.
necessary to detect protein oxidation in various tissues from a variety of organs and animal species. The
OxyIHC test method involves chemical derivatization of protein carbonyl groups with 2,4-
dinitrophenylhydrazine (DNPH). This chemical reaction results in proteins being covalently coupled to DNP
at their carbonyl sites. The DNP-derivatized proteins are then detected using an antibody that specifically
binds to the DNP moiety. Subsequent incubation with biotin conjugated secondary antibody, streptavidin
conjugated HRP, and development using a 3,3’ diaminobenzidine (DAB) staining allows
immunohistochemical detection of protein oxidation.
Application
Research Category
Apoptosis & Cancer
Neuroscience
Apoptosis & Cancer
Neuroscience
Research Sub Category
Neurodegenerative Diseases
Aging
Neurodegenerative Diseases
Aging
The OxyIHC Oxidative Stress Detection Kit contains the chemical & immunological reagents necessary to detect protein oxidation in various tissues from a variety of organs & animal species.
Preparation Note
The OxyIHC kit components should be stored at 2-8ºC. Kit components are stable for 6 months from the
date of receipt if stored and handled properly.
date of receipt if stored and handled properly.
Other Notes
10X Wash Buffer, One 25 mL bottle
10X Antigen Retrieval Buffer, One 1.25 mL bottle
5X Blocking Buffer, One 2.5 mL bottle
Primary Antibody, One 125 mL vial
DAB-A, One 500 mL vial
DAB-B, One 12 mL bottle
Antibody Diluent, One ready to use 12.5 mL bottle
Biotinylated Secondary Antibody, One ready to use 12.5 mL bottle
Streptavidin conjugated HRP, One ready to use 12.5 mL bottle
Hematoxylin, One ready to use 12.5 mL bottle
DNPH Solution, One ready to use 12.5 mL bottle
Derivatization Control Solution, One ready to use 12.5 mL bottle
10X Antigen Retrieval Buffer, One 1.25 mL bottle
5X Blocking Buffer, One 2.5 mL bottle
Primary Antibody, One 125 mL vial
DAB-A, One 500 mL vial
DAB-B, One 12 mL bottle
Antibody Diluent, One ready to use 12.5 mL bottle
Biotinylated Secondary Antibody, One ready to use 12.5 mL bottle
Streptavidin conjugated HRP, One ready to use 12.5 mL bottle
Hematoxylin, One ready to use 12.5 mL bottle
DNPH Solution, One ready to use 12.5 mL bottle
Derivatization Control Solution, One ready to use 12.5 mL bottle
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
signalword
Danger
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 2 - Carc. 1B - Eye Irrit. 2 - Met. Corr. 1 - Muta. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 2 Oral
target_organs
Kidney
Storage Class
6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| S7450 | 04053252612596 |



